The response to sulpiride in social anxiety disorder: D2 receptor function

Journal of Psychopharmacology

Volumn 27, Issue 2, 2013, Pages 146-151

  Bell, Caroline ^a   Bhikha, Shamina ^a   Colhoun, Helen ^a   Carter, Frances ^a   Frampton, Chris ^a   Porter, Richard ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Dopamine; neuroendocrine challenge; social anxiety; sulpiride

Indexed keywords

DOPAMINE 2 RECEPTOR; PLACEBO; PROLACTIN; SULPIRIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MOOD; PLEASURE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SOCIAL PHOBIA; TREATMENT RESPONSE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CROSS-OVER STUDIES; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; PROLACTIN; RECEPTORS, DOPAMINE D2; SOCIAL BEHAVIOR DISORDERS; SULPIRIDE;

EID: 84872876936     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112450778     Document Type: Article

References (36)

1. Argyropoulos SV, Bell CJ, Nutt DJ. Brain function in social anxiety disorder. Psychiatr Clin North Am. 2001 ; 24: 707-722
2. Bell C, Bhika S, Porter R, et al. The response to sulpiride in major depression before and after cognitive behavioural therapy: D2 receptor function. Acta Neuropsychiatr. 2008 ; 20: 199-206
3. Condren RM, Sharifi N, Thakore JH. A preliminary study of dopamine-mediated prolactin inhibition in generalised social phobia. Psychiatry Res. 2002 ; 111: 87-92
4. de Koning P, de Vries MH. A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers. Br J Clin Pharmacol. 1995 ; 39: 7-14
5. Emmanuel NP, Lydiard RB, Ballenger JC. Treatment of social phobia with bupropion. J Clin Psychopharmacol. 1991 ; 11: 276-277
6. Espejo EF. Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res. 1997 ; 762: 281-284
7. First MB, Spitzer RL, Gibbon M, et al Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P, version 2.0, 8/98 revision). New York: Biometrics Research Department, New York State Psychiatric Institute ; 1998 :
8. Gerlach J, Korsgaard S, Clemmesen P, et al. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993 ; 87: 244-252
9. Grant KA, Shively CA, Nader MA, et al. Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse. 1998 ; 29: 80-83
10. Heinz A, Schmidt LG, Reischies FM. Anhedonia in schizophrenic, depressed, or alcohol-dependent patients-neurobiological correlates. Pharmacopsychiatry. 1994 ; 27: 7-10
11. Johnson MR, Lydiard RB, Zealberg JJ, et al. Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry. 1994 ; 36: 425-427
12. Kuruvilla A, Peedicayil J, Srikrishna G, et al. A study of serum prolactin levels in schizophrenia: comparison of males and females. Clin Exp Pharmacol Physiol. 1992 ; 19: 603-606
13. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987 ; 22: 141-173
14. Mathew SJ, Coplan JD, Gorman JM. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry. 2001 ; 158: 1558-1567
15. Mayleben M, Gariepy J, Tancer M, et al. Genetic differences in social behaviour: Neurobiological mechanisms in a mouse model. Biol Psychiatry. 1992 ; 315: 216A
16. McNair DM, Lorr M, Droppleman LF Manual of the Profile of Mood States. San Diego: Educational and Industrial Testing Service ; 1971 :
17. Mehta MA, Sahakian BJ, McKenna PJ, et al. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl). 1999 ; 146: 162-174
18. Mikkelsen EJ, Detlor J, Cohen DJ. School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. Am J Psychiatry. 1981 ; 138: 1572-1576
19. Pallanti S, Quercioli L, Rossi A, et al. The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation. J Clin Psychiatry. 1999 ; 60: 819-823
20. Sareen J, Campbell DW, Leslie WD, et al. Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry. 2007 ; 61: 396-404
21. Scahill L, Leckman JF, Schultz RT, et al. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003 ; 60: 1130-1135
22. Schneier FR, Liebowitz MR, Abi-Dargham A, et al. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry. 2000 ; 157: 457-459
23. Schneier FR, Martinez D, Abi-Dargham A, et al. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety. 2008 ; 25: 1-7
24. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998 ; 59: 22-33
25. Shively CA. Social subordination stress, behavior, and central monoaminergic function in female cynomolgus monkeys. Biol Psychiatry. 1998 ; 44: 882-891
26. Smith S, Wheeler MJ, Murray R, et al. The effects of antipsychotic- induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol. 2002 ; 22: 109-114
27. Snaith RP, Hamilton M, Morley S, et al. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 ; 167: 99-103
28. Spielberger C, Gorsuch R, Lushene R Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press ; 1970 :
29. Tancer ME, Mailman RB, Stein MB, et al. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety. 1994 ; 1: 216-223
30. Tiihonen J, Kuikka J, Bergstrom K, et al. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry. 1997 ; 154: 239-242
31. Tremblay LK, Naranjo CA, Graham SJ, et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry. 2005 ; 62: 1228-1236
32. Verbeeck WJC. The prolactin response to sulpiride in major depression: The role of the D2 receptor in depression. Eur Neuropsychopharmacol. 2001 ; 11: 215-220
33. von Bahr C, Wiesel FA, Movin G, et al. Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers. Psychopharmacology (Berl). 1991 ; 103: 443-448
34. Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969 ; 33: 448-457
35. Williams K, Argyropoulos S, Nutt DJ. Amphetamine misuse and social phobia. Am J Psychiatry. 2000 ; 157: 834-835
36. Willner P, Hale AS, Argyropoulos S. Dopaminergic mechanism of antidepressant action in depressed patients. J Affect Disord. 2005 ; 86: 37-45